HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

A low-income housing cooperative for people with HIV and AIDS is fighting to stay open in San Francisco. On Sunday afternoon, ...

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Vision Group has joined the fight against HIV/AIDS by contributing Sh100 million as a sponsor of this year’s Kabaka Birthday Run.The event precedes the celebrations of the Kabaka’s birthday and aims ...

Prevalence varies by region and is impacted by social stigma, access to preventive medicine and a lack of HIV/AIDS education, ...

The programme has lived up to its promise. The investment of over US$110 billion since being launched has been transformative ...